Samandhy Cedeño Briceño

Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.

Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.

Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PLWH with poor immune reconstitution.

Determinants of virological failure and antiretroviral drug resistance in Mozambique.

Minimal removal of raltegravir by hemodialysis in HIV-infected patients with end-stage renal disease.